Click it and Unblock the Notifications
Latest Updates
-
Too Hot To Handle? How To Stay Cool And Maintain Body Temperature During Heatwave -
Natural ORS: How to Rehydrate Better During India’s Heatwaves -
Celeb Beauty Routine: Aishwarya Raj Bhakuni Says Good Sleep Beats Any Product -
Aloo Matar Recipe: Your Everyday Comfort Curry -
Beyond Taste, It’s Legacy: 5 Heritage Mango Varieties Of Uttar Pradesh From Popular Favourites To Rare Finds -
Akshaya Tritiya 2026: Rituals That Are Good for Your Mind and Body -
Throwback Thursday: Lara Dutta At 48—The Miss Universe 2000 Win That Sparked India’s Global Pageant Dominance -
Irregular Periods Aren’t “Normal”: Why Women Shouldn’t Ignore Cycle Changes, Spotting, And Hormonal Red Flags -
Idli Batter Recipe: Your Foolproof Fermentation Guide -
Horoscope for Today April 16, 2026 - Steady Effort, Clear Gains
biocon JV-Abu Dhabi's Neopharma
New Delhi, Jan 5 (UNI) biocon Ltd today announced a joint venture agreement with Abu Dhabi-based pharmaceutical company Neopharma to manufacture and market bio-pharmaceuticals for the GCC countries.
''The Gulf Cooperation Council (GCC) region is an important market for biocon and the joint venture with Neopharma is an important milestone for biocon's global foray. Neopharma has established a world-class manufacturing facility for finished formulations which was inaugurated by President A P J Abdul Kalam in 2003,'' company Chairman and Managing Director Dr Kiran Mazumdar-Shaw said.
The JV will leverage the leadership position that Neopharma commands in the region under the leadership of Dr B R Shetty and expand Neopharma's existing portfolio with a range of the company's generic and novel therapeutics that encompass diabetes, oncology, auto-immune and immunosuppressive drugs, biocon said.
Continue with Google